Immune Cell Therapy Inc entered the industry of Research and Development Laboratories in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code , which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact edward p cohen by calling (773) 373-8150 during business hours. You can also write to the business’ Single Location at 4737 S Kimbark Avenue, Chicago, Illinois IL 60615. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Immune Cell Therapy Inc |
Representative: | edward p cohen |
Place of Business: | 4737 S Kimbark Avenue, Chicago, IL 60615 |
Contact Number: | (773) 373-8150 |
Type of Service: | Research and Development Laboratories |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2003 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Immune Cell Therapy Inc is a company operating from Cook, Illinois providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 2003 and registered with the SIC code as Research and Development Laboratories, and with the NAICS code as Research and Development Laboratories.
With a current employee count of 1 to 4, Immune Cell Therapy Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative edward p cohen at (773) 373-8150 for related queries, or to locate its Single Location using the coordinates 41.80873,-87.59534.
The Single Location can also be found at the street address 4737 S Kimbark Avenue in Chicago, Illinois 60615 and can be engaged online through the company website at , the company Twitter , and Facebook page .